Ketamine for Sciatica & Chronic Radiculopathy in Baltimore
For when the nerve was decompressed — but the pain kept firing.
Ketamine for sciatica in Baltimore is an off-label IV infusion — $1,499.99 per session, $1,125 for Vitality Circle members — evaluated only for chronic, refractory radicular pain: the central sensitization in the spinal cord that keeps firing months after the nerve compression itself has been treated or resolved. Every infusion is anesthesiologist-led care, under the medical direction of Dr. Brijen Joshi MD, with a Certified Registered Nurse Anesthetist (CRNA) on-site. Ketamine does not decompress a nerve, shrink a herniated disc, or correct stenosis — your spine care continues. It is evaluated once injections or surgery have been exhausted and the pain has outlived the structural cause that started it: chronic radicular pain of 3+ months with burning, allodynia, or spread beyond the original dermatome. Progressive weakness or bladder or bowel changes need urgent spine evaluation, not an infusion. Ketamine is off-label and results vary. $1,499.99/session non-member · $1,125/session Vitality Circle member.
Mon–Fri: 1PM–8PM · Sat: 10AM–2PM
513 Bayview Blvd, Canton, Baltimore MD 21224
(443) 563-1059
Tell Us About Your Situation
Answer a few quick questions — our clinical team reaches out within 1 business day to discuss whether ketamine therapy may be right for you.
Your information is confidential. A clinical team member follows up within 1 business day.
What Ketamine Does and Does Not Do for Sciatica
Sciatica is radicular pain — pain radiating along the sciatic nerve from the lower back into the buttock and leg, usually from compression or irritation of a lumbar nerve root (most commonly L5 or S1). If your pain is centered in the back itself rather than travelling down the leg, our chronic back pain page covers axial pain; sciatica is the leg-dominant, radicular pattern. The honest starting point for this page is a clear statement of what ketamine can and cannot address, because sciatica is a condition where that distinction genuinely matters.
- Does not decompress the nerve root or relieve mechanical compression
- Does not shrink, resorb, or repair a herniated or bulging disc
- Does not correct spinal stenosis, spondylolisthesis, or foraminal narrowing
- Does not replace decompression surgery when surgery is genuinely indicated
- Is not appropriate for acute sciatica that would improve with conservative care
- Does not address red-flag emergencies (cauda equina, progressive weakness)
- The central sensitization component of chronic radicular pain
- Post-decompression persistent radiculopathy — pain continuing after successful surgery
- Chronic sciatica (3+ months) with allodynia, burning, or non-dermatomal spread
- Neuropathic radicular pain maintained centrally after the root cause is treated
- Failed back surgery syndrome (FBSS) with a dominant neuropathic component
- Radicular pain where imaging no longer explains the severity of the pain
In other words: if a nerve is still meaningfully compressed and that compression is driving your pain, the treatment that matters is the one that relieves the compression — physical therapy, epidural steroid injection, or surgery, depending on severity. Ketamine enters the picture when the compression has been addressed or has resolved, and the pain continues anyway — because the nervous system has been sensitized into sustaining it.
Red Flags — When Sciatica Is an Emergency, Not an Infusion Candidate
🚨 These symptoms require immediate emergency care — not a ketamine evaluation
Certain sciatica presentations signal a surgical emergency or serious underlying pathology. If you have any of the following, seek emergency medical care immediately — do not pursue an infusion consultation as a substitute for urgent evaluation:
- Cauda equina syndrome: new bowel or bladder dysfunction (incontinence or retention), saddle anesthesia (numbness in the groin/inner thighs), or severe progressive bilateral leg weakness — a surgical emergency requiring decompression within hours
- Progressive motor weakness: a worsening foot drop or leg weakness that is getting worse over days indicates ongoing nerve damage that may need urgent surgical decompression
- Fever with back pain: possible spinal infection (discitis, epidural abscess) — requires urgent evaluation
- History of cancer with new back pain: possible spinal metastasis — requires prompt imaging
- Trauma-related onset: sciatica following significant trauma may indicate fracture
Acute vs. Chronic Sciatica — Why Timing Determines Everything
The single most important factor in whether ketamine is relevant for sciatica is chronicity. Acute and chronic sciatica are almost different conditions from a treatment standpoint — and conflating them is the most common error in thinking about ketamine for radicular pain.
Most acute sciatica resolves with conservative management — the majority of cases improve substantially within 6 weeks, and many disc herniations spontaneously resorb over months. Acute radicular pain is driven primarily by active nerve root compression and inflammation, which conservative care (activity modification, physical therapy, NSAIDs, and time) or epidural steroid injection addresses directly. Central sensitization has not yet become the dominant mechanism. Ketamine is not appropriate here.
When radicular pain persists beyond 3 months — particularly with allodynia (pain from light touch), burning quality, or pain spreading beyond the original dermatomal distribution — central sensitization has become a dominant driver. At this stage, the pain is being generated and amplified in the spinal cord and brain, increasingly independent of whatever peripheral compression started it. This is the presentation where ketamine's NMDA blockade is mechanistically relevant.
The clearest candidate of all: a patient who had a discectomy or laminectomy that successfully decompressed the nerve — imaging confirms the compression is gone — but the leg pain continued or returned. There is no longer a structural target. The pain is being maintained centrally. This is post-decompression persistent radiculopathy, and it overlaps substantially with failed back surgery syndrome (FBSS).
How Radicular Pain Becomes Centrally Maintained
Understanding how sciatica transitions from a compression problem to a central sensitization problem clarifies exactly where ketamine fits — and why it is irrelevant early and potentially relevant late.
1. Nerve root compression initiates the pain
A herniated disc, stenosis, or foraminal narrowing compresses and inflames a lumbar nerve root — generating the radiating leg pain characteristic of sciatica. At this stage, the pain is driven by the peripheral compression and inflammation, and treatment appropriately targets the compression.
2. Sustained input drives spinal cord sensitization
When nerve root irritation persists, the continuous nociceptive input drives NMDA receptor activation in the spinal cord dorsal horn — establishing central sensitization. The dorsal horn neurons become hyperexcitable, amplifying the pain signal beyond what the compression alone would produce.
3. Sensitization becomes self-sustaining
Over months, the central sensitization can become self-perpetuating — maintaining radicular pain even after the original compression is surgically decompressed or spontaneously resolves. This is why some patients have continued leg pain after a technically successful discectomy, and why imaging may no longer explain the pain.
4. Ketamine's NMDA blockade targets the maintained sensitization
Where central sensitization has become the dominant driver, ketamine's NMDA receptor blockade interrupts the hyperexcitable spinal cord signaling that sustains the chronic radicular pain — targeting the central mechanism rather than a compression that may no longer be present. It does not address any remaining structural compression, which is why patient selection matters so much.
This is why the structural workup comes first: if meaningful compression remains and is driving the pain, decompression is what matters. Ketamine is evaluated for the centrally-maintained pain that persists after structural causes have been appropriately addressed — not as an alternative to addressing them.
The Research on Ketamine for Chronic Radicular & Neuropathic Pain
The evidence base for ketamine in sciatica specifically is more limited than for CRPS or phantom limb pain — an honest assessment matters here. The rationale rests on the broader neuropathic pain and central sensitization literature, applied to the neuropathic, centrally-maintained component of chronic radiculopathy.
The foundational review establishing central sensitization as a distinct pain mechanism driven by NMDA receptor hyperactivity. Directly applicable to chronic radiculopathy, where sustained nerve root input drives spinal cord sensitization that can maintain pain after the compression resolves. Provides the mechanistic basis for evaluating NMDA-targeted therapy in the centrally-maintained component of chronic sciatica.
Review of ketamine's mechanisms and clinical use in chronic neuropathic pain — documenting that NMDA receptor blockade reduces central sensitization and produces analgesia in neuropathic pain conditions. Chronic radiculopathy with neuropathic features falls within this broader category. Emphasized that the strongest responses occur where central sensitization is a dominant mechanism.
Review of failed back surgery syndrome — the persistent pain after spine surgery that overlaps with post-decompression persistent radiculopathy. Documents the neuropathic and centrally-maintained component of FBSS pain that persists after structural correction, providing the clinical context for why a central sensitization-targeted approach is considered when pain continues after technically successful decompression.
An honest evidence summary: ketamine's evidence in sciatica specifically is limited and less robust than in CRPS or phantom limb pain. The rationale is mechanistic — applying the neuropathic pain and central sensitization literature to the centrally-maintained component of chronic radiculopathy. This is why careful patient selection, a completed structural workup, and realistic expectations matter so much for this condition. Individual results vary.
Sciatica Ketamine Pricing at Vita Nova
| Service | Non-Member | Vitality Circle Member | Saving |
|---|---|---|---|
| Ketamine — Chronic Pain / session Off-Label | $1,499.99 | $1,125 | $374.99/session |
If you have a documented co-occurring mental health condition alongside chronic sciatica: chronic radicular pain and low mood share descending pain pathways, and treating the mental health condition may reduce pain through restored descending inhibition — which is why a single evaluation considers your whole pain picture. See our co-occurring depression & chronic pain page.
Self-pay, with a superbill. Every session is anesthesiologist-led care, under the medical direction of Dr. Brijen Joshi MD — Johns Hopkins faculty and Chief of Thoracic Anesthesia at Johns Hopkins Hospital — in a private treatment room with continuous cardiac and vital-sign monitoring, so the price reflects physician-level, monitored care rather than a walk-in drip. Vita Nova is self-pay for ketamine and provides an itemized superbill you can file with your insurance (see our ketamine insurance guide). HSA and FSA accepted; Community Heroes discounts available. Vitality Circle membership ($99.99/month) pays for itself on a single session — the member rate saves $374.99, more than the membership — and adds a free monthly IV or shots plus 25% off premium IVs. Sessions determined individually — first visit? Read the new patient guide. Pricing August 2026 — subject to change. Full pricing guide →
Complementary Treatments Supporting Nerve Health
B12 is essential for myelin synthesis and peripheral nerve health — relevant to the nerve root injury component of chronic radiculopathy. B vitamins support nerve repair and conduction in the injured nerve root. Deficiency can compound neuropathic symptoms and slow nerve recovery. IM delivery achieves reliable repletion.
Magnesium modulates NMDA receptor sensitivity — directly relevant to the central sensitization mechanism in chronic radiculopathy. Magnesium also supports muscle relaxation relevant to the paraspinal and piriformis muscle tension that frequently accompanies sciatica and can compound radicular symptoms.
NAD+ supports mitochondrial function and cellular energy in neural tissue — relevant to nerve health and recovery in chronic nerve root injury. The metabolic demands of chronic pain and the nerve repair process draw on cellular energy reserves that NAD+ therapy supports.
High-dose IV Vitamin C addresses oxidative stress and inflammation relevant to nerve root irritation and the inflammatory component of radiculopathy. Antioxidant support may complement the broader nerve-health approach, particularly in the inflammatory phase of nerve root injury.
Clinical note: These wellness services are not treatments for sciatica or radiculopathy and are not part of Vita Nova's ketamine protocols. They do not address nerve compression. Always discuss supplemental therapy with your spine specialist, neurologist, or prescribing physician — and pursue appropriate structural evaluation first.
Special Pricing for Those Who Serve
Veterans, first responders, and those in physically demanding service occupations carry elevated rates of chronic low back injury and post-surgical spine pain — from cumulative load, trauma, and the physical demands of service.
Sciatica & Ketamine — Questions Answered
Real, high-intent questions from chronic sciatica and radiculopathy patients evaluating ketamine and IV therapy in Baltimore.
The Nerve Was Decompressed.
The Pain Kept Firing —
Ketamine does not decompress nerves or repair discs — and we will tell you honestly if a structural cause needs addressing first. But when the compression has been treated and chronic radicular pain persists through central sensitization, ketamine's NMDA mechanism targets what surgery cannot reach. Off-label, self-pay with an itemized superbill you can file with your insurance. Community Heroes discounts available.
Medically reviewed by Dr. Brijen L. Joshi, MD — Founder & Medical Director, Johns Hopkins Assistant Professor of Anesthesiology & Critical Care Medicine.
Canonical URL: https://vitanovawellnessclinic.com/ketamine-sciatica-baltimore/ · Last reviewed August 2026
